BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+6.01%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$9.04B
AUM Growth
+$9.04B
(-3.5%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
81.82%
Holding
99
New
4
Increased
11
Reduced
16
Closed
9
Top Buys
| 1 |
Immunovant
IMVT
|
$64.1M |
| 2 |
Insmed
INSM
|
$28.5M |
| 3 |
Immunocore
IMCR
|
$24M |
| 4 |
Vaxcyte
PCVX
|
$22.4M |
| 5 |
Celcuity
CELC
|
$16M |
Top Sells
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$199M |
| 2 |
Krystal Biotech
KRYS
|
$26.6M |
| 3 |
Rhythm Pharmaceuticals
RYTM
|
$25.4M |
| 4 |
CRISPR Therapeutics
CRSP
|
$22.3M |
| 5 |
Akero Therapeutics
AKRO
|
$22.2M |
Sector Composition
| 1 | Healthcare | 98.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
76
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $1.77M | 0.02% |
+100,000
| New | +$1.77M |
|
77
vTv Therapeutics
VTVT
$49.4M
| $1.69M | 0.02% |
97,314
| – | – |
|
78
Compass Therapeutics
CMPX
$466M
| $1.04M | 0.01% |
547,498
-1,010,132
| -65% | -$1.92M |
|
79
Neumora Therapeutics
NMRA
$283M
| $1.03M | 0.01% |
1,034,600
| – | – |
|
|
HOOK
80
DELISTED
HOOKIPA Pharma
HOOK
| $878K | 0.01% |
812,814
| – | – |
|
81
Generation Bio
GBIO
$40.3M
| $788K | 0.01% |
1,944,945
| – | – |
|
82
Aligos Therapeutics
ALGS
$75.1M
| $685K | 0.01% |
83,055
| – | – |
|
83
Leap Therapeutics
LPTX
$12M
| $123K | ﹤0.01% |
404,744
-767,431
| -65% | -$234K |
|
84
Century Therapeutics
IPSC
$40.4M
| $115K | ﹤0.01% |
241,684
-555,776
| -70% | -$265K |
|
85
Tyra Biosciences
TYRA
$657M
| $98.6K | ﹤0.01% |
10,607
| – | – |
|
86
Acrivon Therapeutics
ACRV
$42.2M
| $46.3K | ﹤0.01% |
22,809
-30,076
| -57% | -$61.1K |
|
87
Surrozen, Inc. Warrant
SRZNW
$71.9K
| $25K | ﹤0.01% |
833,333
| – | – |
|
|
OPT
88
DELISTED
Opthea Limited American Depositary Shares
OPT
| $0 | ﹤0.01% |
2,087,320
-86,302
| -4% | – |
|
89
PTC Therapeutics
PTCT
$4.41B
| – | – |
-20,400
| Closed | -$921K |
|
90
PMV Pharmaceuticals
PMVP
$82.1M
| – | – |
-322,024
| Closed | -$486K |
|
91
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-1,086,115
| Closed | -$1.55M |
|
92
Mirum Pharmaceuticals
MIRM
$3.75B
| – | – |
-190,476
| Closed | -$7.88M |
|
|
93
Krystal Biotech
KRYS
$4.35B
| – | – |
-169,934
| Closed | -$26.6M |
|
94
Foghorn Therapeutics
FHTX
$298M
| – | – |
-45,027
| Closed | -$213K |
|
95
Biomea Fusion
BMEA
$114M
| – | – |
-1,451,990
| Closed | -$5.63M |
|
96
Arvinas
ARVN
$580M
| – | – |
-405,576
| Closed | -$7.77M |
|
97
Arcturus Therapeutics
ARCT
$467M
| – | – |
-151,329
| Closed | -$2.57M |
|